Marketfoolery

Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future.  Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.